Clinical, microbiological research of the effectiveness of inhalation use of quaternary ammonium antiseptic in the prevention and treatment of infectious respiratory complications in critically ill patients

Abstract

Introduction: The aim is to study the microbiological and clinical efficacy of decamethoxinebased quaternary ammonium antiseptic inhalations in the complex management of respiratory infectious complications in critically ill children.
 Methods: The use of inhalation of antiseptic medicinal decamethoxine (DCM) was studied in patients with ventilator-associated pneumonia (VAP) (n=30), of ages 12-18 years. All patients received standard intensive care according to the guidelines. Inhalations of 5 mL DCM (0.02%) antiseptic per inhalation TID for 7 days in combination with systemic antibiotic therapy were used in the study group (n=15). Clinical microbiological studies and assessment of Toll-like receptor (e.g. TLR-4) serum levels were performed in patients.
 Results: The use of DCM inhalations along with systemic antibiotic therapy improved parameters of dynamic compliance by 3.4-fold and decreased lung resistance by 2.4-fold in patients after 48-72 hours of mechanical ventilation. The microbial spectrum of patients at the beginning of VAP was represented by gram-positive (S. aureus — 28.6%, S. pyogenes — 10.2%) and gramnegative (P. aeruginosa — 16.3%; A. baumannii — 12.24%; K. pneumoniae — 10.2%) pathogens. The pathogens were isolated in the monoculture (20.4%) and in microbial associations (79.6%). A significant decrease by 3 orders of magnitude (log (2.640.43) CFU/mL) in the microbial count in tracheobronchial secretions was determined after 7 days of additional use of DCM inhalations when compared to the initial levels of microbial colonization (p<0.001). The microbial spectrum of the respiratory tract was predominantly represented by S. aureus (27.78%), A. baumannii (11.11%) and E. cloacae (5.56%) in monoculture (61.11%), whereas the microbial count was 4 orders of magnitude higher in the comparison group, versus that of the study group (p<0.001), and was represented by microbial associations (93.33%). A strong correlation was found between the reduction of the gram-negative pathogen count and the decrease of TLR-4 serum levels (r-Pearson=0.893), that almost reached baseline levels after DCM inhalations, while TLR-4 levels remained 2 times higher than baseline levels after the use of systemic antimicrobial therapy alone (p<0.001).
 Conclusion: The use of DCM inhalations in combination with systemic antibiotic therapy provides for an effective reduction of pathogen count in the respiratory tract, leading to the early (48-72h) improvement in lung ventilation and TLR-4 serum levels, and subsequent significant improvement of treatment efficacy in severe VAP patients.

Perioperative hemodynamic protective assessment of adaptive support ventilation usage in pediatric surgical patients

“…Based on patient data and respiratory mechanics (resistance, compliance, and autoPEEP), the safest ventilation parameters are automatically selected with the aim of target minute ventilation. Therefore, ASV can be used in patients with normal lungs and with restrictive or obstructive pulmonary pathology [15][16][17][18].…”

Effectiveness of Using Domestic Quaternary Ammonium Antiseptic in General Medicine and Dentistry (Modern View and Clinical Case)

“…Clinical and microbiological studies of DCM ® inhalation as part of the complex treatment of infectious and respiratory complications showed the effectiveness of antiseptics in reducing the number of gram-negative microorganisms in tracheobronchial secretions after seven days of additional inhalation of DCM ® compared to initial levels of microbial colonization (p <0,001) [34].…”

Dynamics of Changes in Quality of Life and Local Levels of TNF-α and IL-1β in Patients with Acute Viral Rhinitis

“…It is believed that the common cold lasts 5-10 days, after which the symptoms either persist or worsen with the development of post-viral acute rhinosinusitis [4]. Joining the bacterial microflora causes the development of purulent rhinosinusitis, bronchitis, pneumonia [4,5,6,7].…”